medicare coverage for glp 1 Recent Trends in GLP-1 Use and Spending in CMS has announced important updates

Clinical assessment of the ultrasonographic measurement of antral area for estimating preoperative gastric content and volume

How to Get Rid of Sulfur Burps on GLP-1 Medications Introduction Have you ever found yourself in an embarrassing moment, surrounded by friends or colleagues, only to be hit with a burp that smells distinctly like rotten eggs

On those days I dont push it

[1] Increases in amylase and lipase In trials, tirzepatide-treated patients had a mean increase from baseline in amylase of 20% to 25% and an increase in lipase of 28% to 35%

Urva S, Coskun T, Loh MT et al (2022) LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicenter, double-blind, placebo-controlled, randomised, multiple-ascending dose trial

As research about the impacts of GLP-1s on addiction continues, one thing should be made clear to the public: GLP-1s are currently not FDA-approved to treat SUD